Ozempic (semaglutide) is a once-weekly GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults
Both semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors based on rodent studies, and both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2
The Impact of Melatonin on Colon Cancer Cells Resistance to Doxorubicin in an in Vitro Study. International Journal of Molecular Sciences, vol
This issue is particularly common in individuals with obesity and type 2 diabetes, where insulin resistance plays a key role
Dr Dinesh Mahendran, Consultant Endocrinologist at The Metabolic Clinic, was invited to share insights on CNA938 on the complex relationship between obesity, hormones, stress and mental health, and explains why weight gain is often driven by metabolic and hormonal factors rather than willpower alone